Priority: Impact of rHuEPO on CKD Anemia Care
Abbreviations ▼
CKD: Chronic kidney disease; rHuEPO: Recombinant human erythropoietin.
References ▼
1. Garrido P, Ribeiro S, Fernandes J, et al. Resistance to recombinant human erythropoietin therapy in a rat model of chronic kidney disease associated anemia. Int J Mol Sci. 2016;17(1):28. 2. Katagiri D, Hinoshita F. Benefits and risks of erythrocyte-stimulating agents. World J Clin Urol. 2014;3(3):258–263.
LMRC Code: GGI-CO-A1-AQS-300027678-BANNERS-G24-0782
.
Cresp
Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients